Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion type Assertion NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_head.
- NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion description "[MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_provenance.
- NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion evidence source_evidence_literature NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_provenance.
- NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion SIO_000772 23636450 NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_provenance.
- NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion wasDerivedFrom befree-2016 NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_provenance.
- NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_assertion wasGeneratedBy ECO_0000203 NP1074221.RA0HPKSUWQxVcAam8KcHMsz0z-EtN1N5jNcGxymWck1O4130_provenance.